1. Home
  2. ATYR vs IBEX Comparison

ATYR vs IBEX Comparison

Compare ATYR & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • IBEX
  • Stock Information
  • Founded
  • ATYR 2005
  • IBEX 2017
  • Country
  • ATYR United States
  • IBEX United States
  • Employees
  • ATYR N/A
  • IBEX N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • IBEX EDP Services
  • Sector
  • ATYR Health Care
  • IBEX Technology
  • Exchange
  • ATYR Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • ATYR 451.3M
  • IBEX 386.9M
  • IPO Year
  • ATYR 2015
  • IBEX 2020
  • Fundamental
  • Price
  • ATYR $5.35
  • IBEX $30.22
  • Analyst Decision
  • ATYR Strong Buy
  • IBEX Hold
  • Analyst Count
  • ATYR 5
  • IBEX 2
  • Target Price
  • ATYR $23.25
  • IBEX $27.00
  • AVG Volume (30 Days)
  • ATYR 5.0M
  • IBEX 89.7K
  • Earning Date
  • ATYR 08-07-2025
  • IBEX 09-11-2025
  • Dividend Yield
  • ATYR N/A
  • IBEX N/A
  • EPS Growth
  • ATYR N/A
  • IBEX 48.53
  • EPS
  • ATYR N/A
  • IBEX 2.25
  • Revenue
  • ATYR N/A
  • IBEX $535,666,000.00
  • Revenue This Year
  • ATYR $478.72
  • IBEX $9.12
  • Revenue Next Year
  • ATYR $1,899.26
  • IBEX $5.80
  • P/E Ratio
  • ATYR N/A
  • IBEX $12.93
  • Revenue Growth
  • ATYR N/A
  • IBEX 5.35
  • 52 Week Low
  • ATYR $1.67
  • IBEX $16.35
  • 52 Week High
  • ATYR $7.29
  • IBEX $32.08
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 52.99
  • IBEX 60.17
  • Support Level
  • ATYR $4.58
  • IBEX $28.26
  • Resistance Level
  • ATYR $5.03
  • IBEX $29.93
  • Average True Range (ATR)
  • ATYR 0.34
  • IBEX 0.80
  • MACD
  • ATYR -0.01
  • IBEX 0.12
  • Stochastic Oscillator
  • ATYR 66.09
  • IBEX 97.38

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: